Randomized Clinical Trial: Perioperative Rifaximin Is Not Associated with Enhanced Functional and Volumetric Recovery after Major Liver Resection (ARROW).

Saved in:
Bibliographic Details
Title: Randomized Clinical Trial: Perioperative Rifaximin Is Not Associated with Enhanced Functional and Volumetric Recovery after Major Liver Resection (ARROW).
Authors: Bednarsch, J.1 (AUTHOR), Czigany, Z.1 (AUTHOR), Loosen, S.H.2,3 (AUTHOR), Heij, L.R.1,4 (AUTHOR), Ruckgaber, L.1 (AUTHOR), Maes, H.1 (AUTHOR), Krause, J.-P.1 (AUTHOR), Reen, M.1 (AUTHOR), Toteva, B.1 (AUTHOR), Vosdellen, T.1 (AUTHOR), Bruners, P.5 (AUTHOR), Lang, S.A.1 (AUTHOR), Ulmer, T.F.1 (AUTHOR), Roderburg, C.2,3 (AUTHOR), Luedde, T.2,3 (AUTHOR), Neumann, U.P.1,6 (AUTHOR)
Source: HPB (1365-182X). 2022 Supplement1, Vol. 24, pS167-S167. 1p.
Database: Academic Search Ultimate
Description
ISSN:1365182X
DOI:10.1016/j.hpb.2022.05.334